CN1419934A - Medicinal composition for treating brain apoplexy - Google Patents
Medicinal composition for treating brain apoplexy Download PDFInfo
- Publication number
- CN1419934A CN1419934A CN 02156504 CN02156504A CN1419934A CN 1419934 A CN1419934 A CN 1419934A CN 02156504 CN02156504 CN 02156504 CN 02156504 A CN02156504 A CN 02156504A CN 1419934 A CN1419934 A CN 1419934A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- weight
- rhizoma
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine composition for treating cerebral apoplexy is prepared from 12 Chinese-medicinal materials including astragalus root, arisaema tuber, Chinese angelica root, Chuan-xiong rhizome, etc. Its advantages are high curative effect and no toxic by-effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of apoplexy.
Background technology
Apoplexy is a kind of main commonly encountered diseases that causes death, disables, and is exactly one of " the swollen lattice of wind consumptive disease " four disaster diseases from ancient times.The Chinese medicine traditional rationality is thought: the generation of apoplexy is many, and QI-blood circulation is not normal by patient's internal organs imbalance of YIN and YANG, contains in the phlegm-damp, multiple be satiated with food or inducements such as chamber fatigue or exopathogen invasion and attack because of the angry or comfortable wine of being worried, thus cloudy lose in " under, YANG overacting in the uppper part; liver-yang is opened cruelly; sunization endogenous wind, disturbance QI and blood, bleeding resulting from adverse flow of QI; hold expectorant under the arm and hold fire under the arm; hoodwink thinking, the horizontal channel tunnel of scurrying forms the soldier and so loses consciousness the servant, the disease of hemiplegia.Modern medicine is clear recognizes that the main pathological change of primary disease is that cerebral hemorrhage (or infraction) cerebral edema one intracranial hypertension one nervus centralis is killd the back hemiplegia.
Technology contents
The object of the present invention is to provide a kind ofly has remarkable result to the aphasia that causes of treatment apoplexy, hemiplegia etc., and takes safety, pharmaceutical composition without any side effects.
The present invention is achieved through the following technical solutions: choose crude drug
A group: Radix Astragali 60-120 weight portion Rhizoma Arisaematis 30-60 weight portion
Rhizoma Pinelliae 30-60 weight portion RADIX ACONITI LATERALIS PREPARATA 30-60 weight portion
B group: Radix Ginseng Rubra 5-30 weight portion Radix Angelicae Sinensis 10-50 weight portion
Rhizoma Chuanxiong 10-50 weight portion Rhizoma Cyperi 10-50 weight portion
Rhizoma Acori Graminei 10-50 weight portion Radix Curcumae 10-50 weight portion
Radix Polygalae 5-30 weight portion rhizoma sparganic 10-50 weight portion
Rhizoma Curcumae 10-50 weight portion Semen Persicae 5-30 weight portion
Radix Salviae Miltiorrhizae 10-50 weight portion Caulis Spatholobi 10-50 weight portion
Ramulus Cinnamomi 5-30 weight portion RHIZONA GASTRODIAE 5-30 weight portion
Radix Rehmanniae Preparata 10-50 weight portion Fructus Corni 10-50 weight portion
Herba Cistanches 10-50 weight portion Radix Morindae Officinalis 5-30 weight portion
Gekko Swinhonis 10-50 weight portion Pheretima 10-50 weight portion
Bombyx Batryticatus 10-50 weight portion eupolyphaga 10-50 weight portion
Ramulus Mori 30-90 weight portion Retinervus Luffae Fructus 10-50 weight portion
Optimum ratio of the present invention is: choose crude drug
A group: Radix Astragali 90 weight portion Rhizoma Arisaematis 45 weight portions
Rhizoma Pinelliae 45 weight portion RADIX ACONITI LATERALIS PREPARATA 45 weight portions
B group: Radix Ginseng Rubra 15 weight portion Radix Angelicae Sinensis 30 weight portions
Rhizoma Chuanxiong 30 weight portion Rhizoma Cyperis 30 weight portions
Rhizoma Acori Graminei 30 weight portion Radix Curcumaes 30 weight portions
Radix Polygalae 15 weight portion rhizoma sparganic 30 weight portions
Rhizoma Curcumae 30 weight portion Semen Persicaes 15 weight portions
Radix Salviae Miltiorrhizae 30 weight portion Caulis Spatholobis 30 weight portions
Ramulus Cinnamomi 15 weight portion RHIZONA GASTRODIAE 15 weight portions
Radix Rehmanniae Preparata 30 weight portion Fructus Corni 30 weight portions
Herba Cistanches 30 weight portion Radix Morindae Officinaliss 15 weight portions
Gekko Swinhonis 30 weight portion Pheretimas 30 weight portions
Bombyx Batryticatus 30 weight portion eupolyphaga 30 weight portions
Ramulus Mori 60 weight portion Retinervus Luffae Fructuss 30 weight portions
Two groups of medicines of A, B are respectively charged in the container, add cold water dipping 20-40 minute; At first A is organized and fried in shallow oil 1-3 hour after medicine is fried boiling with slow fire again, add boil back 20-60 minute of B group medicine, leach first liquid of boiling medicine, add water again and fry in shallow oil out in right amount, back 20-40 minute of boiling leaches second liquid of boiling medicine, and fries in shallow oil for the third time so again.The mixing of totally one place is concentrated with three decocting liquids, adds sodium benzoate 10-40 weight portion, staticly settles 8-16 hour; The leaching supernatant, through 105 degree circulation steam sterilizations 20-40 minute promptly.
One, clinical experiment
The present invention treats apoplexy hemiplegia 62 examples, and the course of disease is the shortest 1 month, and is the longest 15 years, and wherein male's 39 examples account for 63%, and women's 23 examples account for 37%, minimum 35 years old of age, maximum 68 years old.62 routine patients all are subjected to Drug therapy after a while in the outer court, but symptom can not control, and take the present invention after 1 month, and produce effects accounts for 45 examples in 62 examples, accounts for 72.5%, and 17 examples that take a turn for the better account for 27.5%.
Two. criterion of therapeutical effect
Produce effects: the treatment back patient walking that can stand.
Effectively: there is consciousness at paralysed disease position.
Invalid: change of illness state is slow.
Three, result
The present invention's energy replenishing QI and blood, the stasis of blood of reducing phlegm, wind-damp dispelling, the meridian dredging have wind-expelling pain-stopping, dehumidifying eliminating phlegm, relaxing muscles and tendons and activating QI and blood in the collateral, and aphasia, hemiplegia that the treatment apoplexy is caused have remarkable result, and take safety, have no side effect.
Embodiment
Choose crude drug:
A group: Radix Astragali 90 gram Rhizoma Arisaematis 45 gram Rhizoma Pinelliae 45 gram RADIX ACONITI LATERALIS PREPARATA 45 grams
B group: Radix Ginseng Rubra 15 gram Radix Angelicae Sinensis 30 gram Rhizoma Chuanxiongs 30 gram Rhizoma Cyperis 30 grams
Rhizoma Acori Graminei 30 gram Radix Curcumaes 30 gram Radix Polygalaes 15 gram rhizoma sparganic 30 grams
Rhizoma Curcumae 30 gram Semen Persicaes 15 gram Radix Salviae Miltiorrhizaes 30 gram Caulis Spatholobis 30 grams
Ramulus Cinnamomi 15 gram RHIZONA GASTRODIAE 15 gram Radix Rehmanniaes Preparata 30 gram Fructus Corni 30 grams
Herba Cistanches 30 gram Radix Morindae Officinaliss 15 gram Gekko Swinhonis 30 gram Pheretimas 30 grams
Bombyx Batryticatus 30 gram eupolyphaga 30 gram Ramulus Moris 60 gram Retinervus Luffae Fructuss 30 grams
Two groups of medicines of A, B are respectively charged in the container, add cold water dipping 30 minutes; Again A is organized and fried in shallow oil again 2 hours after medicine is fried boiling with slow fire, add B group medicine and boiled back 40 minutes, leach first liquid of boiling medicine, add water again and fry in shallow oil out in right amount, boiled back 40 minutes, leach second liquid of boiling medicine, fry in shallow oil so more for the third time; The mixing of totally one place is concentrated with three decocting liquids, receives 2250 milliliters of medicinal liquids altogether, adds sodium benzoate 25 grams, staticly settles 12 hours; The leaching supernatant is an oral liquid formulation, is sub-packed in 250 milliliters of high temperature bottles, adorns 9 bottles altogether, through 105 degree circulation steam sterilizations 30 minutes promptly; Every day 3 times, each 100 milliliters.
Claims (5)
1, a kind of pharmaceutical composition for the treatment of apoplexy is characterized in that said composition is to be made by following crude drug:
Radix Astragali 60-120 weight portion Rhizoma Arisaematis 30-60 weight portion
Rhizoma Pinelliae 30-60 weight portion RADIX ACONITI LATERALIS PREPARATA 30-60 weight portion
Radix Ginseng Rubra 5-30 weight portion Radix Angelicae Sinensis 10-50 weight portion
Rhizoma Chuanxiong 10-50 weight portion Rhizoma Cyperi 10-50 weight portion
Rhizoma Acori Graminei 10-50 weight portion Radix Curcumae 10-50 weight portion
Radix Polygalae 5-30 weight portion rhizoma sparganic 10-50 weight portion
Rhizoma Curcumae 10-50 weight portion Semen Persicae 5-30 weight portion
Radix Salviae Miltiorrhizae 10-50 weight portion Caulis Spatholobi 10-50 weight portion
Ramulus Cinnamomi 5-30 weight portion RHIZONA GASTRODIAE 5-30 weight portion
Radix Rehmanniae Preparata 10-50 weight portion Fructus Corni 10-50 weight portion
Herba Cistanches 10-50 weight portion Radix Morindae Officinalis 5-30 weight portion
Gekko Swinhonis 10-50 weight portion Pheretima 10-50 weight portion
Bombyx Batryticatus 10-50 weight portion eupolyphaga 10-50 weight portion
Ramulus Mori 30-90 weight portion Retinervus Luffae Fructus 10-50 weight portion.
2, pharmaceutical composition according to claim 1 is characterized in that this combination made by following crude drug:
Radix Astragali 90 weight portion Rhizoma Arisaematis 45 weight portion Rhizoma Pinelliae 45 weight portions
RADIX ACONITI LATERALIS PREPARATA 45 weight portion Radix Ginseng Rubra 15 weight portion Radix Angelicae Sinensis 30 weight portions
Rhizoma Chuanxiong 30 weight portion Rhizoma Cyperis 30 weight portion Rhizoma Acori Graminei 30 weight portions
Radix Curcumae 30 weight portion Radix Polygalaes 15 weight portion rhizoma sparganic 30 weight portions
Rhizoma Curcumae 30 weight portion Semen Persicaes 15 weight portion Radix Salviae Miltiorrhizaes 30 weight portions
Caulis Spatholobi 30 weight portion Ramulus Cinnamomi 15 weight portion RHIZONA GASTRODIAE 15 weight portions
Radix Rehmanniae Preparata 30 weight portion Fructus Corni 30 weight portion Herba Cistanches 30 weight portions
Radix Morindae Officinalis 15 weight portion Gekko Swinhonis 30 weight portion Pheretimas 30 weight portions
Bombyx Batryticatus 30 weight portion eupolyphaga 30 weight portion Ramulus Moris 60 weight portions
Retinervus Luffae Fructus 30 weight portions.
3, pharmaceutical composition according to claim 1 and 2 is characterized in that said composition can be made into acceptable clinically any dosage form.
4, preparation of drug combination method according to claim 1 and 2 is characterized in that this method for two groups of medicines of A, B are respectively charged in the container, adds cold water dipping 20-40 minute; At first A is organized and fried in shallow oil 1-3 hour after medicine is fried boiling with slow fire again, add boil back 20-60 minute of B group medicine, leach first liquid of boiling medicine, add water again and fry in shallow oil out in right amount, back 20-40 minute of boiling leaches second liquid of boiling medicine, and fries in shallow oil so more for the third time; The mixing of totally one place is concentrated with three decocting liquids, adds sodium benzoate 10-40 weight portion, staticly settles 8-16 hour; The leaching supernatant, through 105 degree circulation steam sterilizations 20-40 minute promptly.
5, preparation of drug combination method according to claim 4 is characterized in that this method for two groups of medicines of A, B are respectively charged in the container, adds cold water dipping 30 minutes; Again A is organized and fried in shallow oil again 2 hours after medicine is fried boiling with slow fire, add B group medicine and boiled back 40 minutes, leach first liquid of boiling medicine, add water again and fry in shallow oil out in right amount, boiled back 40 minutes, leach second liquid of boiling medicine, fry in shallow oil so more for the third time; The mixing of totally one place is concentrated with three decocting liquids, receives 2250 milliliters of medicinal liquids altogether, adds sodium benzoate 25 grams, staticly settles 12 hours; The leaching supernatant, through 105 degree circulation steam sterilizations 30 minutes promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB02156504XA CN1319586C (en) | 2002-12-16 | 2002-12-16 | Medicinal composition for treating brain apoplexy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB02156504XA CN1319586C (en) | 2002-12-16 | 2002-12-16 | Medicinal composition for treating brain apoplexy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1419934A true CN1419934A (en) | 2003-05-28 |
| CN1319586C CN1319586C (en) | 2007-06-06 |
Family
ID=4752764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB02156504XA Expired - Fee Related CN1319586C (en) | 2002-12-16 | 2002-12-16 | Medicinal composition for treating brain apoplexy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1319586C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1298338C (en) * | 2005-07-21 | 2007-02-07 | 陈际华 | Cardiovascular and cerebrovascular disease treating medicine |
| CN1299723C (en) * | 2005-06-14 | 2007-02-14 | 毛顺卿 | Medicine for treating rhomboembolia type angiitis |
| CN100353967C (en) * | 2004-04-09 | 2007-12-12 | 浙江康恩贝集团养颜堂制药有限公司 | Preparation of blood-nourishing Angelica capsule |
| CN103566306A (en) * | 2013-11-07 | 2014-02-12 | 王春霞 | Traditional Chinese medicine for treating cerebral apoplexy and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056296C (en) * | 1996-12-26 | 2000-09-13 | 郭贵江 | Capsule for apoplexy |
| CN1112203C (en) * | 2000-11-02 | 2003-06-25 | 郑国芃 | Apoplexy curing decoction |
-
2002
- 2002-12-16 CN CNB02156504XA patent/CN1319586C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100353967C (en) * | 2004-04-09 | 2007-12-12 | 浙江康恩贝集团养颜堂制药有限公司 | Preparation of blood-nourishing Angelica capsule |
| CN1299723C (en) * | 2005-06-14 | 2007-02-14 | 毛顺卿 | Medicine for treating rhomboembolia type angiitis |
| CN1298338C (en) * | 2005-07-21 | 2007-02-07 | 陈际华 | Cardiovascular and cerebrovascular disease treating medicine |
| CN103566306A (en) * | 2013-11-07 | 2014-02-12 | 王春霞 | Traditional Chinese medicine for treating cerebral apoplexy and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1319586C (en) | 2007-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN1539447A (en) | Medicated rehabilitation wine for treating premonitory apoplexy, sequela of apoplexy and obastrcution of qi in chest | |
| CN1319586C (en) | Medicinal composition for treating brain apoplexy | |
| CN104043045A (en) | Pharmaceutical composition for treating optic atrophy | |
| CN100509025C (en) | A medicine for treating diabetes | |
| CN102228648B (en) | Chinese medicinal composition for treating icterohepatitis | |
| CN1208075C (en) | Healthy fermentative wine preparation | |
| CN1247086A (en) | Process for making medical wine for treating rheumatism | |
| CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
| CN1663577A (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN101361897B (en) | Traditional Chinese medicine for treating femur head necrosis | |
| CN101406596A (en) | Medicament for treating dry eye | |
| CN1075727C (en) | Shentong capsule and preparing method thereof | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1277577C (en) | Chinese traditional medicine for treating cerebral thrombosis, preparation method and application | |
| CN1788776A (en) | Chinese traditional medicine for treating diabetes retinopathy | |
| CN1371726A (en) | A Chinese medicinal decoction pill for treating hepatitis B | |
| CN100482259C (en) | Chinese medicine for treating cervical spondylosis | |
| CN1745835A (en) | Diabetes mellitus pill and prescription thereof | |
| CN100350957C (en) | Composition for curing psoriasis | |
| CN102225132A (en) | Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof | |
| CN101028401A (en) | Oral Chinese medicine for treating difficult menstruation | |
| CN1336221A (en) | Angiocardiopathy treating traditional Chinese medicine | |
| CN1270738C (en) | Artemisia apiacea pill for removing summer heat and curing cold |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070606 Termination date: 20121216 |